ERBB2 and triple-negative breast carcinoma: Tang et al [15] indicated that young patients with tumors classified as luminal B type were at increased risk of poor DFS and OS; in contrast, no significant DFS or OS difference between young and elderly was observed in HER2-positive or triple negative breast cancer.